Skip to main content
. 2021 May 6;2021:5580102. doi: 10.1155/2021/5580102

Figure 5.

Figure 5

Actual values vs. predicted values using PLS regression ((a) doxorubicin, (b) daunorubicin, and (c) epirubicin).